Patient characteristics: —demographic and socioeconomic variables compared across patients who received cardiovascular disease risk assessments in the NOCAR project and those who did not
| RA | AS | PsA | SpA | |||||||||
| In NOCAR n=2004 | Not in NOCAR n=2479 | P values | In NOCAR n=722 | Not in NOCAR n=941 | P values | In NOCAR n=700 | Not in NOCAR n=1228 | P values | In NOCAR n=219 | Not in NOCAR n=496 | P values | |
| Age | 62.0 (52.9–69.0) | 63.0 (52.0–70.5) | 0.29 | 49.0 (43.0–57.0) | 50.8 (40.0–62.0) | 0.01 | 53.0 (46.0–60.0) | 55.0 (46.0–65.0) | <0.001 | 47.0 (40.3–55.0) | 46.0 (37.0–56.0) | 0.91 |
| Female sex | 1650 (82.4) | 1874 (75.5) | <0.001 | 332 (46.0) | 489 (51.9) | 0.02 | 405 (57.9) | 709 (57.7) | 0.93 | 139 (63.5) | 321 (64.7) | 0.75 |
| Education, years | 12.4±3.4 | 12.4±3.5 | 0.92 | 13.7±3.1 | 13.5±3.2 | 0.13 | 13.4±3.1 | 13.0±3.1 | 0.02 | 13.7±3.1 | 13.6±3.1 | 0.65 |
| Working, current | 846 (42.5) | 783 (37.0) | <0.001 | 476 (67.0) | 485 (57.5) | <0.001 | 395 (57.2) | 504 (49.1) | 0.001 | 139 (64.7) | 264 (59.7) | 0.22 |
| Pensioner, current | 597 (30.0) | 647 (30.5) | 0.71 | 69 (9.7) | 117 (13.9) | 0.01 | 96 (13.9) | 197 (19.2) | 0.004 | 9 (4.2) | 37 (8.4) | <0.05 |
| Sick leave, current | 65 (3.3) | 84 (4.0) | 0.23 | 33 (4.6) | 41 (4.9) | 0.85 | 36 (5.2) | 51 (5.0) | 0.82 | 19 (8.8) | 33 (7.5) | 0.54 |
| Disabled, pensioner or rehabilitation | 517 (24.4) | 467 (23.5) | 0.49 | 162 (22.8) | 205 (24.3) | 0.50 | 194 (28.1) | 265 (25.8) | 0.29 | 45 (20.9) | 106 (24.0) | 0.38 |
| Smoker, current | 502 (25.2) | 536 (25.2) | 0.97 | 213 (29.8) | 219 (25.9) | 0.09 | 198 (28.6) | 281 (27.4) | 0.58 | 60 (28.0) | 92 (20.7) | 0.04 |
| Smoking, ever | 1284 (64.6) | 1377 (65.1) | 0.73 | 428 (61.2) | 507 (60.3) | 0.71 | 395 (58.6) | 683 (67.6) | <0.001 | 125 (58.4) | 245 (55.6) | 0.49 |
| BMI | 26.1±4.5 | 26.1±4.7 | 0.88 | 26.5±4.2 | 26.4±4.4 | 0.81 | 28.1±4.7 | 27.7±4.7 | <0.05 | 26.7±4.5 | 26.7±4.8 | 0.93 |
| BMI>30 | 1071 (60.8) | 1132 (59.1) | 0.28 | 415 (65.3) | 448 (62.6) | 0.31 | 485 (77.2) | 675 (72.8) | <0.05 | 128 (64.3) | 242 (63.0) | 0.76 |
| Weight group | 0.18 | 0.07 | 0.002 | 0.17 | ||||||||
| Underweight | 30 (1.6) | 48 (2.4) | 2 (0.3) | 6 (0.8) | 1 (0.1) | 11 (1.1) | 0 (0.0) | 8 (1.9) | ||||
| Normal weight | 755 (39.4) | 746 (36.8) | 205 (29.8) | 285 (36.2) | 129 (19.3) | 242 (24.7) | 64 (30.6) | 147 (35.3) | ||||
| Overweight | 722 (37.6) | 763 (37.7) | 285 (41.4) | 293 (37.2) | 266 (39.9) | 371 (37.9) | 86 (41.1) | 158 (38.0) | ||||
| Obese | 411 (21.4) | 479 (23.2) | 197 (28.6) | 204 (25.9) | 271 (40.6) | 354 (36.2) | 59 (28.3) | 103 (24.8) | ||||
Underweight: BMI<18.5; normal weight: BMI 18.5–25.0; overweight: BMI 25.1–30.0; obese: BMI>30.
AS, ankylosing spondylitis; BMI, body mass index; NOCAR, NOrwegian Collaboration of Atherosclerosis in patients with Rheumatic diseases; PsA, psoriatic arthritis; RA, rheumatoid arthritis; SpA, spondyloarthropathy.